Ana Clara Aprotosoaie

Dr. Ana Clara Aprotosoaie


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2015 in Comprehensive Reviews in Food Science and Food Safety
Verified
Journal Article
Closed access
PDF file
AAAna Clara Aprotosoaie
Ana Clara Aprotosoaie
SLSimon Vlad Luca
Simon Vlad Luca
AMAnca Miron
Anca Miron

17 December 2016 in Diseases
Verified
Journal Article
Open access
PDF file
AAAna Clara Aprotosoaie
Ana Clara Aprotosoaie
AMAnca Miron
Anca Miron
Adriana TrifanAdriana Trifan
Adriana Trifan
Simon Vlad LucaSimon Vlad Luca
Simon Vlad Luca
Irina Iuliana COSTACHE-ENACHEIrina Iuliana COSTACHE-ENACHE
Irina Iuliana COSTACHE-ENACHE
Cocoa is a rich source of high-quality antioxidant polyphenols. They comprise mainly catechins (29%–38% of total polyphenols), anthocyanins (4% of total polyphenols) and proanthocyanidins (58%–65% of total polyphenols). A growing body of experimental and epidemiological evidence highlights that the intake of cocoa polyphenols may reduce the risk of cardiovascular events. Beyond antioxidant properties, cocoa polyphenols exert blood pressure lowering activity, antiplatelet, anti-inflammatory, metabolic and anti-atherosclerotic effects, and also improve endothelial function. This paper reviews the role of cocoa polyphenols in cardiovascular protection, with a special focus on mechanisms of action, clinical relevance and correlation between antioxidant activity and cardiovascular health.

2 September 2019 in Cardiovascular Therapeutics
Verified
Journal Article
Open access
PDF file
ICIrina-Iuliana Costache
Irina-Iuliana Costache
AMAnca Miron
Anca Miron
MHMonica Hancianu
Monica Hancianu
VAViviana Aursulesei
Viviana Aursulesei
ACAlexandru Dan Costache
Alexandru Dan Costache
AAAna Clara Aprotosoaie
Ana Clara Aprotosoaie
The growing use of plant products among patients with cardiovascular pharmacotherapy raises the concerns about their potential interactions with conventional cardiovascular medicines. Plant products can influence pharmacokinetics or/and pharmacological activity of coadministered drugs and some of these interactions may lead to unexpected clinical outcomes. Numerous studies and case reports showed various pharmacokinetic interactions that are characterized by a high degree of unpredictability. This review highlights the pharmacokinetic clinically relevant interactions between major conventional cardiovascular medicines and plant products with an emphasis on their putative mechanisms, drawbacks of herbal products use, and the perspectives for further well-designed studies.

7 October 2024 in Polymers
Verified
Journal Article
Open access
PDF file
RDRoxana Petronela Damaschin
Roxana Petronela Damaschin
LMLazar Marinela Maria
Lazar Marinela Maria
CGClaudiu Augustin Ghiorghita
Claudiu Augustin Ghiorghita
AAAna Clara Aprotosoaie
Ana Clara Aprotosoaie
Irina VolfIrina Volf
Irina Volf
Maria Valentina DinuMaria Valentina Dinu
Maria Valentina Dinu
Porous hydrogels have brought more advantages than conventional hydrogels when used as chromatographic materials, controlled release vehicles for drugs and proteins, matrices for immobilization or separation of molecules and cells, or as scaffolds in tissue engineering. Polysaccharide-based porous hydrogels, in particular, can address challenges related to bioavailability, solubility, stability, and targeted delivery of natural antioxidant compounds. Their porous structure enables the facile encapsulation and controlled release of these compounds, enhancing their therapeutic effectiveness. In this context, in the present study, the cryogelation technique has been adopted to prepare novel dextran (Dx)-based porous hydrogels embedding polyphenol-rich natural extract from Picea abies spruce bark (SBE). The entrapment of the SBE within the Dx network was proved by FTIR, SEM, and energy-dispersive X-ray spectroscopy (EDX). SEM analysis showed that entrapment of SBE resulted in denser cryogels with smaller and more uniform pores. Swelling kinetics confirmed that higher concentrations of Dx, EGDGE, and SBE reduced water uptake. The release studies demonstrated the effective stabilization of SBE in the Dx-based cryogels, with minimal release irrespective of the approach selected for SBE incorporation, i.e., during synthesis (~3–4%) or post-synthesis (~15–16%). In addition, the encapsulation of SBE within the Dx network endowed the hydrogels with remarkable antioxidant and antimicrobial properties. These porous biomaterials could have broad applications in areas such as biomedical engineering, food preservation, and environmental protection, where stability, efficacy, and safety are paramount.